Abstract
Sensory processing is a common target in autism spectrum disorder (ASD) research, yet the latent structure of sensory experience is disputed. Researchers frequently explore the presence of “subtypes” to categorize sensory heterogeneity, but such discrete models can fail to capture the intrinsic geometry of phenotypic data. In this study, we aim to characterize heterogeneous sensory profiles in ASD and explore if the same characterization can describe neurobiological function. First, we apply unsupervised spectral manifold dimensionality reduction to item-level Sensory Profile data from a large cohort of autistic participants (n=223) to compare categorical subtyping against continuous models. The behavioral results reveal unstable and irreproducible subtyping solutions; instead, sensory processing differences are best characterized as a continuous, non-linear manifold of sensory severity.
To determine the neurobiological relevance of this sensory gradient, we employed voxel-wise linear mixed-effects modeling of insula-seeded functional connectivity (n=63). We demonstrate that sensory severity predicts a significant decoupling between the insula and sensorimotor cortices during externally driven stimulation involving motion stimuli, but not during resting state. This finding supports the interpretation that sensory-related neural hypoconnectivity is context-dependent and not reflective of intrinsic traits. Further, we identify a significant sex-by-sensory gradient interaction, indicating heightened sensitivity of connectivity patterns to sensory severity in autistic males. These findings indicate that sensory atypicality in ASD points toward a continuous regulatory manifold linked to disrupted social-sensory integration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this work was provided by NIH R01 MH100028
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data from the ACE GENDAAR project used in this study were collected across four sites: Yale University, Harvard University and Boston Children's Hospital, the University of California, Los Angeles, the University of Washington and Seattle Children's Research Institute, and the University of Virginia. All procedures were approved by the institutional review boards of participating sites and conducted in accordance with the Declaration of Helsinki. The study received institutional review board (IRB) approvals as follows: Yale as lead institution (IRB: 1206010363; Pelphrey), UCLA (IRB# 10-000387-CR-00008; Bookheimer), Boston Children's Hospital (IRB-P00004852; Nelson), and with Seattle Children's Hospital (IRB 00000277; Webb) as a reliant site to Yale. George Washington University (GWU) assumed the role of lead institution (IRB 031802; Pelphrey) and the ACE project is now governed as a single-site IRB at the University of Virginia (UVA; IRB-HSR-220423; Pelphrey). The ACE GENDAAR Data Coordination Center (DCC) was originally governed by UCLA, subsequently by the University of Southern California (USC; HS-18-00467, HS-13-00668; Van Horn), and presently by UVA (IRB-HSR-22078; Van Horn). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Adjusted author list, removed the table of Sensory Profile items per a co-author request.
Data Availability
All data used in this study are publicly available at the NIMH Data Archive (NDA) under the collections #2021 and #2804.
